220 related articles for article (PubMed ID: 11997203)
1. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.
Weitzner MA; Moncello J; Jacobsen PB; Minton S
J Pain Symptom Manage; 2002 Apr; 23(4):337-45. PubMed ID: 11997203
[TBL] [Abstract][Full Text] [Related]
2. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
Stearns V; Slack R; Greep N; Henry-Tilman R; Osborne M; Bunnell C; Ullmer L; Gallagher A; Cullen J; Gehan E; Hayes DF; Isaacs C
J Clin Oncol; 2005 Oct; 23(28):6919-30. PubMed ID: 16192581
[TBL] [Abstract][Full Text] [Related]
4. Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
Capriglione S; Plotti F; Montera R; Luvero D; Lopez S; Scaletta G; Aloisi A; Serra GB; Angioli R
Gynecol Oncol; 2016 Dec; 143(3):584-588. PubMed ID: 27751589
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
Stearns V; Beebe KL; Iyengar M; Dube E
JAMA; 2003 Jun; 289(21):2827-34. PubMed ID: 12783913
[TBL] [Abstract][Full Text] [Related]
7. Pilot evaluation of paroxetine for treating hot flashes in men.
Loprinzi CL; Barton DL; Carpenter LA; Sloan JA; Novotny PJ; Gettman MT; Christensen BJ
Mayo Clin Proc; 2004 Oct; 79(10):1247-51. PubMed ID: 15473404
[TBL] [Abstract][Full Text] [Related]
8. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes.
Carpenter JS; Elam JL; Ridner SH; Carney PH; Cherry GJ; Cucullu HL
Oncol Nurs Forum; 2004 May; 31(3):591-5598. PubMed ID: 15146224
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
10. Pilot evaluation of citalopram for the relief of hot flashes.
Barton DL; Loprinzi CL; Novotny P; Shanafelt T; Sloan J; Wahner-Roedler D; Rummans TA; Christensen B; Dakhill SR; Martin LS
J Support Oncol; 2003; 1(1):47-51. PubMed ID: 15352642
[TBL] [Abstract][Full Text] [Related]
11. Hot flashes in breast cancer survivors: Frequency, severity and impact.
Chang HY; Jotwani AC; Lai YH; Jensen MP; Syrjala KL; Fann JR; Gralow J
Breast; 2016 Jun; 27():116-21. PubMed ID: 27065357
[TBL] [Abstract][Full Text] [Related]
12. Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer.
Naoe M; Ogawa Y; Shichijo T; Fuji K; Fukagai T; Yoshida H
Prostate Cancer Prostatic Dis; 2006; 9(3):275-8. PubMed ID: 16786037
[TBL] [Abstract][Full Text] [Related]
13. Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program.
Palesh OG; Mustian KM; Peppone LJ; Janelsins M; Sprod LK; Kesler S; Innominato PF; Roth T; Manber R; Heckler C; Fiscella K; Morrow GR
Sleep Med; 2012 Oct; 13(9):1184-90. PubMed ID: 22858235
[TBL] [Abstract][Full Text] [Related]
14. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
15. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine versus placebo for women in midlife after hormone therapy discontinuation.
Soares CN; Joffe H; Viguera AC; Petrillo L; Rydzewski M; Yehezkel R; Somley B; Cohen LS
Am J Med; 2008 Feb; 121(2):159-162.e1. PubMed ID: 18261506
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer and hot flashes. Options for relief.
Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
[No Abstract] [Full Text] [Related]
18. Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer.
Li T; Yang J; Lv Y; Yin F; Xu L; Liu H; Zheng Q; Li L
Breast Cancer Res Treat; 2019 Feb; 173(3):511-520. PubMed ID: 30390215
[TBL] [Abstract][Full Text] [Related]
19. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
20. Management of hot flashes in breast cancer survivors and men with prostate cancer.
Stearns V
Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
